Processa Pharmaceuticals, Inc. Operating Cash Flow
Processa Pharmaceuticals, Inc. (PCSA) reported Operating Cash Flow of -$5.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.00M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.59M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.90M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.48M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$11.39M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$11.25M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$8.06M.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$9.61M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 27 month | Net Cash Provided by (Used in) Operating Activities 30 month | Net Cash Provided by (Used in) Operating Activities 33 month | Net Cash Provided by (Used in) Operating Activities 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.59M 10-Q · filed 2026-08-14 | -$8.49M derived: sum of 3 quarters · filed 2026-08-14 | -$11.97M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$3.59M 10-Q · filed 2026-05-07 | -$6.49M derived: sum of 2 quarters · filed 2026-05-07 | -$9.98M derived: sum of 3 quarters · filed 2026-05-07 | -$12.25M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$6.38M derived: sum of 2 quarters · filed 2026-03-18 | -$8.66M derived: sum of 3 quarters · filed 2026-08-14 | -$11.39M 10-K · filed 2026-03-18 | ||||||||
| 2025-09-30 | -$3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.75M derived: sum of 2 quarters · filed 2026-08-14 | -$8.48M 10-Q · filed 2025-11-06 | -$10.73M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-06-30 | -$2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.00M 10-Q · filed 2026-08-14 | -$7.25M derived: sum of 3 quarters · filed 2026-08-14 | -$10.85M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$2.73M 10-Q · filed 2026-05-07 | -$4.98M derived: sum of 2 quarters · filed 2026-05-07 | -$8.58M derived: sum of 3 quarters · filed 2026-05-07 | -$11.93M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||
| 2024-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$5.85M derived: sum of 2 quarters · filed 2026-03-18 | -$9.20M derived: sum of 3 quarters · filed 2026-03-18 | -$11.25M 10-K · filed 2026-03-18 | ||||||||
| 2024-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$6.95M derived: sum of 2 quarters · filed 2025-11-06 | -$9.00M 10-Q · filed 2025-11-06 | -$11.12M derived: sum of 4 quarters · filed 2025-11-06 | ||||||||
| 2024-06-30 | -$3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.39M 10-Q · filed 2025-08-07 | -$7.52M derived: sum of 3 quarters · filed 2025-08-07 | -$9.28M derived: sum of 4 quarters · filed 2025-08-07 | ||||||||
| 2024-03-31 | -$2.05M 10-Q · filed 2025-05-08 | -$4.17M derived: sum of 2 quarters · filed 2025-05-08 | -$5.93M derived: sum of 3 quarters · filed 2025-05-08 | -$8.00M derived: sum of 4 quarters · filed 2025-05-08 | ||||||||
| 2023-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.88M derived: sum of 2 quarters · filed 2025-03-20 | -$5.95M derived: sum of 3 quarters · filed 2025-03-20 | -$8.06M 10-K · filed 2025-03-20 | ||||||||
| 2023-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$3.83M derived: sum of 2 quarters · filed 2024-10-30 | -$5.94M 10-Q · filed 2024-10-30 | -$8.44M derived: sum of 4 quarters · filed 2024-10-30 | ||||||||
| 2023-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$4.18M 10-Q · filed 2024-08-13 | -$6.68M derived: sum of 3 quarters · filed 2024-08-13 | -$9.65M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||
| 2023-03-31 | -$2.11M 10-Q · filed 2024-05-10 | -$4.61M derived: sum of 2 quarters · filed 2024-05-10 | -$7.59M derived: sum of 3 quarters · filed 2024-05-10 | -$9.92M derived: sum of 4 quarters · filed 2024-05-10 | ||||||||
| 2022-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$5.47M derived: sum of 2 quarters · filed 2024-03-29 | -$7.80M derived: sum of 3 quarters · filed 2024-03-29 | -$9.61M 10-K · filed 2024-03-29 | ||||||||
| 2022-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$5.30M derived: sum of 2 quarters · filed 2023-11-13 | -$7.11M 10-Q · filed 2023-11-13 | -$9.83M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||
| 2022-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.13M 10-Q · filed 2023-08-10 | -$6.86M derived: sum of 3 quarters · filed 2023-08-10 | -$8.41M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | -$1.80M 10-Q · filed 2023-05-15 | -$4.53M derived: sum of 2 quarters · filed 2023-05-15 | -$6.08M derived: sum of 3 quarters · filed 2023-05-15 | -$8.28M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||
| 2021-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$4.28M derived: sum of 2 quarters · filed 2023-03-30 | -$6.47M derived: sum of 3 quarters · filed 2023-03-30 | -$8.72M 10-K · filed 2023-03-30 | ||||||||
| 2021-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.75M derived: sum of 2 quarters · filed 2022-11-08 | -$5.99M 10-Q · filed 2022-11-08 | -$8.27M derived: sum of 4 quarters · filed 2022-11-08 | ||||||||
| 2021-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$4.44M 10-Q · filed 2022-08-11 | -$6.71M derived: sum of 3 quarters · filed 2022-08-11 | -$6.68M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||
| 2021-03-31 | -$2.24M 10-Q · filed 2022-05-12 | -$4.52M derived: sum of 2 quarters · filed 2022-05-12 | -$4.49M derived: sum of 3 quarters · filed 2022-05-12 | -$4.84M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$2.25M derived: sum of 2 quarters · filed 2022-03-30 | -$2.60M derived: sum of 3 quarters · filed 2022-03-30 | -$3.14M 10-K · filed 2022-03-30 | ||||||||
| 2020-09-30 | $29.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$321.39K derived: sum of 2 quarters · filed 2021-11-12 | -$867.84K 10-Q · filed 2021-11-12 | -$1.48M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||
| 2020-06-30 | -$350.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$897.03K 10-Q · filed 2021-08-12 | -$1.51M derived: sum of 3 quarters · filed 2021-08-12 | -$2.23M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||
| 2020-03-31 | -$546.45K 10-Q · filed 2021-05-13 | -$1.16M derived: sum of 2 quarters · filed 2021-05-13 | -$1.88M derived: sum of 3 quarters · filed 2021-05-13 | -$2.69M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||
| 2019-12-31 | -$613.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$1.34M derived: sum of 2 quarters · filed 2021-03-25 | -$2.14M derived: sum of 3 quarters · filed 2021-03-25 | -$2.75M 10-K · filed 2021-03-25 | ||||||||
| 2019-09-30 | -$721.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$1.53M derived: sum of 2 quarters · filed 2020-11-12 | -$2.14M 10-Q · filed 2020-11-12 | -$1.24M 10-Q · filed 2019-11-14 | -$2.60M derived: sum of 4 quarters · filed 2020-11-12 | |||||||
| 2019-06-30 | -$807.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$1.41M 10-Q · filed 2020-08-05 | -$1.02M 10-Q · filed 2019-08-14 | -$1.88M derived: sum of 3 quarters · filed 2020-08-05 | -$2.89M derived: sum of 4 quarters · filed 2020-08-05 | |||||||
| 2019-03-31 | -$607.43K 10-Q · filed 2020-05-15 | -$492.43K 10-Q · filed 2019-05-14 | -$1.07M derived: sum of 2 quarters · filed 2020-05-15 | -$2.08M derived: sum of 3 quarters · filed 2020-05-15 | -$3.25M derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | -$463.98K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | -$1.47M derived: sum of 2 quarters · filed 2020-03-06 | -$2.64M derived: sum of 3 quarters · filed 2020-03-06 | -$3.71M 10-K · filed 2020-03-06 | ||||||||
| 2018-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$2.17M derived: sum of 2 quarters · filed 2019-11-14 | -$3.24M 10-Q · filed 2019-11-14 | -$3.92M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||
| 2018-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$2.23M 10-Q · filed 2019-08-14 | -$2.91M derived: sum of 3 quarters · filed 2019-08-14 | -$3.53M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||
| 2018-03-31 | -$1.07M 10-Q · filed 2019-05-14 | -$1.74M derived: sum of 2 quarters · filed 2019-05-14 | -$2.37M derived: sum of 3 quarters · filed 2019-05-14 | -$2.66M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2017-12-31 | -$675.79K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | -$1.30M derived: sum of 2 quarters · filed 2019-04-08 | -$1.60M derived: sum of 3 quarters · filed 2019-04-08 | -$1.65M 10-K/A · filed 2019-04-08 | ||||||||
| 2017-09-30 | -$622.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$920.13K derived: sum of 2 quarters · filed 2018-11-14 | -$978.82K 10-Q · filed 2018-11-14 | -$249.97K 10-Q · filed 2017-11-20 | -$3.10M derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | -$297.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$355.93K 10-Q · filed 2018-08-14 | -$76.29K 10-Q · filed 2017-10-04 | -$2.47M derived: sum of 3 quarters · filed 2018-08-14 | -$2.46M derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | -$58.70K 10-Q · filed 2018-05-21 | -$1.60K 10-Q · filed 2017-10-04 | -$2.18M derived: sum of 2 quarters · filed 2018-05-21 | -$2.16M derived: sum of 3 quarters · filed 2018-05-21 | -$2.16M derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | -$2.10M derived: sum of 2 quarters · filed 2018-04-16 | -$2.10M derived: sum of 3 quarters · filed 2018-04-16 | -$2.16M 10-K · filed 2018-04-16 | -$43.20K 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | $16.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $14.16K derived: sum of 2 quarters · filed 2017-11-20 | -$36.21K 10-Q · filed 2017-11-20 | -$82.28K derived: sum of 4 quarters · filed 2017-11-20 | ||||||||
| 2016-06-30 | -$2.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | -$52.94K 10-Q · filed 2017-10-04 | -$99.01K derived: sum of 3 quarters · filed 2017-10-04 | -$146.24K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2016-03-31 | -$50.37K 10-Q · filed 2017-10-04 | -$96.44K derived: sum of 2 quarters · filed 2017-10-04 | -$143.66K derived: sum of 3 quarters · filed 2017-10-04 | -$420.19K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2015-12-31 | -$46.07K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$93.30K derived: sum of 2 quarters · filed 2017-09-25 | -$369.82K derived: sum of 3 quarters · filed 2017-09-25 | -$871.91K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | -$47.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$323.75K derived: sum of 2 quarters · filed 2017-09-08 | -$825.84K 10-Q · filed 2017-09-08 | -$1.28M derived: sum of 4 quarters · filed 2017-09-08 | ||||||||
| 2015-06-30 | -$276.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$778.61K 10-Q · filed 2017-08-30 | -$1.23M derived: sum of 3 quarters · filed 2017-08-30 | -$1.77M derived: sum of 4 quarters · filed 2017-08-30 | ||||||||
| 2015-03-31 | -$502.09K 10-Q · filed 2017-08-07 | -$957.66K derived: sum of 2 quarters · filed 2017-08-07 | -$1.50M derived: sum of 3 quarters · filed 2017-08-07 | -$2.21M derived: sum of 4 quarters · filed 2017-08-07 | ||||||||
| 2014-12-31 | -$455.57K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$995.81K derived: sum of 2 quarters · filed 2017-06-19 | -$1.70M derived: sum of 3 quarters · filed 2017-06-19 | -$2.69M 10-K · filed 2017-06-19 | -$2.70M 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | -$540.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$1.25M derived: sum of 2 quarters · filed 2015-12-01 | -$2.24M 10-Q · filed 2015-12-01 | -$2.70M derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | -$708.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$1.70M 10-Q · filed 2015-08-19 | -$2.16M derived: sum of 3 quarters · filed 2015-08-19 | -$2.87M derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | -$987.74K 10-Q · filed 2015-05-15 | -$1.45M derived: sum of 2 quarters · filed 2015-05-15 | -$2.16M derived: sum of 3 quarters · filed 2015-05-15 | -$2.93M derived: sum of 4 quarters · filed 2015-05-15 | -$6.12M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | -$462.54K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | -$1.17M derived: sum of 2 quarters · filed 2015-04-14 | -$1.95M derived: sum of 3 quarters · filed 2015-04-14 | -$2.54M 10-K · filed 2015-04-14 | -$5.14M 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | -$709.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$1.48M derived: sum of 2 quarters · filed 2014-11-13 | -$2.08M 10-Q · filed 2014-11-13 | -$2.72M derived: sum of 4 quarters · filed 2014-11-13 | -$4.67M 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | -$773.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$1.37M 10-Q · filed 2014-08-19 | -$2.01M derived: sum of 3 quarters · filed 2014-08-19 | -$2.67M derived: sum of 4 quarters · filed 2014-08-19 | -$3.96M 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | -$592.97K 10-Q · filed 2014-05-14 | -$1.24M derived: sum of 2 quarters · filed 2014-05-14 | -$1.90M derived: sum of 3 quarters · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$647.83K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$1.30M derived: sum of 2 quarters · filed 2014-03-27 | -$1.89M 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | -$656.25K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$1.24M 10-Q · filed 2013-11-08 | ||||||||||
| 2012-06-30 | -$588.42K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |